How to synthesize Lorlatinib?
Lorlatinib is an oral small molecule inhibitor of anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (ROS1) kinase developed by Pfizer for the treatment of ALK-positive non-small cell lung cancer.
Jan 2,2024 InhibitorsThe Synthetic method of Larotrectinib (LOXO-101)
Larotrectinib (LOXO-101) is the first highly potent and selective small molecule ATP competitive inhibitor of all three TRK kinases (TRKA, TRKB, and TRKC) to enter clinical development.
Jan 2,2024 APIProperties and Applications of Silicone Oil
Silicone oils are constituted of a linear chain of siloxane repeating units (–Si–O) and a variety of side chains (radical side groups).
Jan 2,2024 APISodium carbonate: Applications and Security
Sodium carbonate is the disodium carbonate salt with an alkaline base. It is widely used in industry.
Jan 2,2024 APIPolyethylene glycol immunogenicity: anti-polyethylene glycol antibody
Polyethylene glycol (PEG) is a flexible, hydrophilic simple polymer that is physically attached to peptides, proteins, nucleic acids, liposomes, and nanoparticles to reduce renal clearance, block anti
Jan 2,2024 APIThe Biological function of Aviptadil
Aviptadil is a synthetic Vasoactive Intestinal Peptide (VIP) that has been studied in respiratory disease conditions.
Jan 2,2024 Biochemical EngineeringThe Pharmacokinetics and uses of Teriparatide acetate
The anabolic drug teriparatide acetate has been introduced as a novel therapeutic agent for osteoporosis.
Jan 2,2024 Biochemical EngineeringSynthesis of Ripretinib
Ripretinib was synthesized by construction of a 1,6-naphtholide involving the junction of an α-aryl ester and appropriately functionalized 4-aminopyridine.
Jan 2,2024 InhibitorsPralsetinib: Synthesis and Introduction
Pralsetinib (BLU-667) is synthesised using bromopyridine as a raw material by chemical reaction.
Jan 2,2024 InhibitorsHow is Pemigatinib Synthesised?
Pemigatinib is synthesised using pyrrolopyridine as a raw material, firstly by synthesis of Pemigatinib Morpholine Intermediate and then by reduction, cyclisation and other reactions.
Jan 2,2024 Inhibitors












